Building Bridges Between Pharmacy and Addiction Medicine Specialists

Pharmacists regularly encounter people whose relationship with alcohol, prescription opioids or other substances is causing real harm. In a typical day at a community pharmacy in Brisbane or Adelaide, a patient picking up a strong analgesic, a schedule 8 item or even nicotine replacement therapy may reveal cues that suggest dependence. Recognising those cues is only the first step. Translating that recognition into a meaningful referral is where many pharmacists feel less confident, particularly when the destination is an addiction medicine specialist rather than a general practitioner.

Australia has a relatively well-developed network of addiction medicine physicians, many of them credentialed through the Royal Australasian College of Physicians. Yet the pathways between pharmacy counters and these clinicians are often informal, built on chance encounters rather than deliberate protocols. With alcohol-related harm continuing to affect regional and metropolitan communities and with prescription opioid stewardship under the spotlight from the Therapeutic Goods Administration, the case for structured collaboration has rarely been stronger.

A formal referral relationship does not mean handing every patient over. It means establishing trust on both sides, knowing exactly who takes what kind of patient, and creating a flow of information that respects privacy while supporting continuity of care. The rest of this article walks through what that looks like in practice for pharmacists working in Australia, drawing on insights from a long-running pharmacy practice blog written by an Australian pharmacist.

Understanding the Australian Addiction Treatment Landscape

Addiction medicine in Australia sits within a broader ecosystem of public and private services. Public alcohol and drug treatment services operate across each state and territory, often delivered through Local Health Networks in NSW, Hospital and Health Services in Queensland, and equivalent bodies elsewhere. Private addiction medicine specialists typically work out of consulting rooms in capital cities, with telehealth now widely accepted under Medicare arrangements. Pharmacists who understand this dual public-private structure can match patients to the right level of care much more accurately.

The credentialing body for addiction medicine physicians is the Royal Australasian College of Physicians, with the Chapter of Addiction Medicine responsible for advanced training. Fellows of the chapter often work alongside psychiatrists, pain specialists and general practitioners with extended skills. Knowing whether a local specialist holds that fellowship, or is a general practitioner with a particular interest in addiction, helps frame the kind of cases that are appropriate to send across.

State-based real-time prescription monitoring systems also shape referrals. SafeScript in Victoria, QScript in Queensland, Tasmania's DORA system and equivalent arrangements in other jurisdictions give pharmacists and prescribers a shared view of monitored medicines. Pharmacists who flag concerning prescribing or supply patterns can use these systems as a starting point for a clinical conversation rather than a punitive referral, which reframes the entire interaction as supportive.

Identifying Qualified Specialists in Your Catchment Area

The first practical task is mapping who actually takes referrals nearby. Public service directories are usually the simplest starting point, with each state health department publishing contact details for their alcohol and other drug intake lines. Pharmacists working in regional Western Australia or rural Victoria will find that telehealth significantly widens the catchment, particularly after the permanent Medicare telehealth items introduced during the pandemic were extended into ongoing arrangements.

Professional directories maintained by bodies such as the Royal Australian College of General Practitioners and the Australian Medical Association can also help, although listings may not always distinguish between a general addiction interest and specialised credentialing. A quick phone call to a specialist's rooms, asking about current wait times and accepted referral letters, gives more usable information than any online profile.

For pharmacists interested in a more curated approach, resources such as an international perspective on pharmacy-led collaboration outline how overseas counterparts structure joint care, with several principles transferring well to Australian settings. Combine that with local directories, and a workable referral map usually emerges within a few weeks.

Making the First Approach Count

A cold call to a specialist's practice can feel awkward, but most addiction medicine physicians welcome thoughtful enquiries from pharmacists. The framing matters: introduce yourself as a community pharmacist from a specific suburb, mention the patient population you serve, and explain that you are looking to establish a reliable referral pathway rather than a one-off favour. This positions the relationship as professional and ongoing.

Bringing something to the first conversation accelerates trust. A short written outline of your pharmacy's processes around dose administration aids, opioid substitution therapy or needle and syringe programs demonstrates that you already speak the clinical language. In states with large opioid substitution therapy populations, such as New South Wales and Victoria, demonstrating familiarity with the relevant state and federal pharmacotherapy regulations is particularly valuable.

Specialist reception staff are often the gatekeepers. Treat that initial administrative call with the same respect you would offer a medical practice, confirm the right clinician for the patient group, and ask about preferred referral formats. Some practices in Melbourne and Sydney now accept secure electronic referrals through Argus or HealthLink, while others still rely on fax or encrypted email. Knowing the local preference avoids weeks of lost correspondence.

Structuring the Referral Itself

The actual referral letter should be brief and clinically focused. Include the patient's presenting concern, relevant medication history, results of any monitoring you have access to through SafeScript or QScript, and a clear statement of what you are asking the specialist to do. Avoid speculative diagnoses; describe behaviours and risk factors instead. This clinical humility is often appreciated by addiction specialists, who then read the letter as collegial.

Consent is central. Pharmacists should confirm that the patient understands the referral and consents to the exchange of information, ideally in writing and held in the dispensing record. Where patients express hesitation, the referral can still proceed as a recommendation rather than a formal handover, giving the patient agency. Documenting that conversation protects the pharmacist and the specialist alike.

After the referral, a short follow-up with the patient within a few weeks closes the loop and signals to the specialist that you are practising collaboratively. In regional areas where travel to specialists can involve long drives or ferry trips, this follow-up conversation is often the most meaningful part of continuity for the patient, and it reassures the specialist that their treatment plan will be supported at the primary interface.

Sustaining the Partnership Through Communication

A referral relationship is not built on a single transaction. Once a patient has moved through the pathway, take time to reflect on what worked and what did not, then feed that back to the specialist. A short email acknowledging receipt of a shared care plan, or flagging a minor concern with a dispensing issue, builds reciprocity. Specialists notice pharmacists who communicate, and they prioritise those relationships when capacity is tight.

Joining local networks accelerates this. Many Primary Health Networks across Australia run medication advisory committees, pain management working groups, or alcohol and other drug reference groups. Pharmacists who attend these meetings in cities such as Perth, Hobart or Canberra often find addiction medicine specialists in the same room, and informal trust forms naturally before any formal referral pathway is needed.

Continuing professional development also strengthens the bridge. Events hosted by professional pharmacy bodies, hospital-based grand rounds and conferences run under the auspices of the Australasian Professional Society on Alcohol and other Drugs all provide structured opportunities to connect. Showing up consistently at these gatherings signals seriousness and keeps your clinical knowledge aligned with current practice.

Funding, Reimbursement and Regulatory Realities

Pharmacists should be aware that funding arrangements for collaborative work have shifted several times in recent years. The Pharmaceutical Benefits Scheme continues to underpin much of the dispensing revenue, while professional services such as medication management reviews, dose administration aids and opioid stewardship reviews bring separate remuneration. Where a referral relationship feeds into a formal MedsCheck or a Home Medicines Review, the pharmacist is more directly compensated for the time spent coordinating care.

Regulatory expectations around privacy, particularly under the Privacy Act and the Australian Privacy Principles, set boundaries for information sharing. Pharmacists should keep referral letters short, store them securely within the dispensing system, and avoid forwarding identifying details through unsecured channels. Specialists expect the same standards, and a shared commitment to confidentiality becomes another quiet trust signal.

Registration requirements via the Australian Health Practitioner Regulation Agency frame what each profession can lawfully contribute. Pharmacists cannot prescribe, but they can initiate conversations, support pharmacotherapy, and refer. Recognising the scope of your role, and trusting the specialist to operate within theirs, is the foundation of a partnership that improves patient outcomes without overstepping either boundary.

Practical Steps to Launch the Relationship

• Begin with a directory audit of addiction medicine specialists, public intake lines and telehealth options within a reasonable catchment.
• Draft a brief one-page referral template covering presenting concern, medication history, monitoring data and the specific request.
• Make a structured introductory call to one specialist practice, offering a short written summary of your pharmacy's relevant services.
• Document patient consent carefully and store all correspondence within the dispensing record.
• Schedule quarterly check-ins, even if only informal, to keep the partnership warm.

Take the Next Step Today

Building a referral relationship with addiction medicine specialists is one of the most impactful collaborations a pharmacist can invest in this decade. Start small, stay consistent, and let the relationship deepen over a few patient cycles rather than expecting perfection from the first referral. The specialists you reach out to will remember the pharmacist who cared enough to call, and the patients will benefit from a health system that finally feels connected across the pharmacy counter and the specialist's consulting room.